Valuation check: HGEN's profit margin is -3137.32%, below the Healthcare sector average of 15.29%.
Get informed when a big investor buys or sells
+ FollowAs of Mar 2023
Trailing 12 months ending Mar 2023
Humanigen (HGEN) currently reports a profit margin of -3137.32% as of March 2023. That compares with -4641.13% in the prior-year period — up 32.4% year over year. That is below the Healthcare sector average of 15.29%. Use the charts on this page to explore Humanigen's profit margin history and peer comparisons.
Humanigen's profit margin increased from -4641.13% to -3137.32% — a 32.4% year-over-year increase (period ending March 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Humanigen's profit margin of -3137.32% is lower than the Healthcare sector average of 15.29%. That is roughly 20614.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Humanigen's current -3137.32% should be judged against Healthcare norms (sector average: 15.29%) and against HGEN's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -3137.32%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.29%. From there, open related valuation or income-statement pages for Humanigen, and consider following HGEN for alerts when major investors trade the stock.